Assessing the use of FreeStyle Libre Pro with HbA1c in diabetes management

Not Applicable

Completed

• Conditions: Diabetes Mellitus (Diabetes); Nutritional, Metabolic, Endocrine; Diabetes Mellitus

• Registration Number: ISRCTN36033130
• Lead Sponsor: Abbott Diabetes Care Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-10-14
• Study Completion: 2019-12-23
• Last Update Posted: 24 February 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 44

Inclusion Criteria

1. Age at least 18 years
2. Type 2 diabetes, on oral glucose-lowering medication, or, oral glucose-lowering medication and biphasic insulin

Exclusion Criteria

1. Currently prescribed basal insulin
2. Currently prescribed bolus insulin
3. Currently prescribed glucagon-like peptide 1 (GLP-1) without being prescribed biphasic insulin
4. Concomitant disease or condition that may compromise patient safety including and not limited to; cystic fibrosis, severe mental illness, a diagnosed or suspected eating disorder or any uncontrolled long term medical condition
5. Has a pacemaker or any other neurostimulators
6. Currently receiving dialysis treatment or planning to receive dialysis during the study
7. Women who are pregnant, plan to become pregnant or become pregnant during the study
8. Participating in another study of a glucose monitoring device or drug that could affect glucose measurements or management
9. Known (or suspected) allergy to medical grade adhesives
10. In the investigator’s opinion the participant is unsuitable to participate due to any other cause/reason

Study & Design

• Study Type: Interventional
• Study Design: Not specified